![](/img/cover-not-exists.png)
P3-026: A novel Bayesian dose-escalation Phase Ib study design investigating combination of the mammalian target of rapamycin (mTOR) inhibitor RAD001 with standard chemotherapy in patients with lung cancer
Di Scala, Lilla, Pylvánáinen, Ilona, Molloy, Betty, Kunz, Tiffany, Miller, Neil, Proot, Pieter, Dimitrijevic, Sasa, Zuber, EmmanuelVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000283783.66748.a4
Date:
August, 2007
File:
PDF, 188 KB
english, 2007